Eptinezumab in Adults With Migraine and Medication Overuse Headache

Summary

This study evaluates the efficacy of eptinezumab to prevent migraine and headache in patients with the combined diagnosis of migraine and medication overuse headache

Timeline

Start

2021-02-17

Primary completion

2022-05-23

Completion

2022-09-30

Publications

• Yu S, Zhou J, Luo G, Xiao Z, Ettrup A, Jansson G, Florea I, Ranc K, Pozo-Rosich P. Efficacy and safety of eptinezumab in patients with chronic migraine and medication-overuse headache: a randomized, double-blind, placebo-controlled study. BMC Neurol. 2023 Dec 15;23(1):441. doi: 10.1186/s12883-023-03477-z.

Drugs

Indications